SUBSTITUTED SEVEN-MEMBERED HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES
- Application ID: EP11784011
- Status: █ PATENT GRANTED
This EP application has the IPC class C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. is specialized in C07. Merck & Co. Inc. is specialised in C07 (ORGANIC CHEMISTRY). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.